Bayer has completed its acquisition of Perfuse Therapeutics, Inc., a biopharmaceutical company focused on treatments for ischemia-induced ocular diseases, according ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions